Skip to main content

Cost-effective reimbursement analysis for medical technologies in Europe

Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 20 EU countries

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Publication Digest: Early access programs for medical devices in France: Overview of recent reforms and outcomes (2015-2022)

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Martin et al. examined three Early Access Programs in France designed to expedite patient access to innovative medical devices. These included Innovation Funding, which has granted temporary coverage to 16 out of 35 applications (46%) since 2015; Transitional Coverage (PECT), which has approved six out of 11 applications (64%) since 2021; and Transitional coverage for digital health applications (PECAN), introduced in 2022, which provided favorable coverage opinion for a telemonitoring solution in its first year. The authors highlighted how targeted funding and regulatory frameworks can bridge the gap between innovation and accessibility, offering valuable insights for the development of a harmonized European framework.

Access the full-text article here.